Del Nido Cardioplegia Randomized Trial
Stopped early · Not applicable
Conditions studied: Cardiac Perfusion
In brief
The use of a modified depolarizing cardioplegia solution in adult cardiac surgery would allow for prolonged re-dosing intervals while providing equivalent myocardial protection. The use of del Nido solution has been used extensively in congenital heart surgery for over 25 years. The primary objective is to determine whether expanding this technique to adult cardiac surgery will confer significant benefits in both surgical workflow and patient clinical outcome. The investigators hypotheses with regard to the del Nido solution will demonstrate (1) a non-inferior delivery to the current blood-based cardioplegia strategy in functional recovery or clinical outcome, and (2) superior delivery to the current blood-based cardioplegia strategy in cost analyses.
Key facts
- Study ID
- NCT02442050
- Run by
- Inova Health Care Services
- People needed
- 99
- Starts
- 2015-01-01
- Expected to finish
- 2017-04-04
- Last updated by the study team
- 2022-01-12
Who can join
Age: 19 and older, up to 79. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects able to receive and provide informed consent
- Elective surgical procedures requiring CPB and myocardial arrest
- Isolated coronary artery bypass graft (CABG) surgery or single valve surgery, with or without CABG
You may not qualify if…
- Previous cardiac surgery
- Patients with preoperative inotropic pharmacological support
- Patients on preoperative mechanical circulatory support
- Patients with an implanted pacemaker or implantable cardioverter defibrillator
- Patients with non-isolated CABG or other non-CABG procedures with single valve surgery
Where it is running
- CVTSA — Falls Church, Virginia, United States
- Inova Heart and Vascular Institute — Falls Church, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.